Investor Overview

Investor Presentation
Financial News
Jun 27, 2018

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQX: MDNAF), a clinical stage immunotherapy company, today announced its operational and financial results for the year...

May 29, 2018

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQX: MDNAF), a clinical stage immuno-oncology company, is pleased to announce that executives from Medicenna will attend...

May 2, 2018

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQX: MDNA), a clinical stage immunotherapy company, announced today that half the patients in the ongoing Phase 2b study...

Stock Quote
TSXMDNA
Stock Chart
TSXMDNA
Upcoming Events
Tuesday, June 5, 2018

Boston, MA Convention Centre, Theater 1

Investor Contact
For more investor information, Please contact:
 
Elizabeth Williams, Chief Financial Officer
Email Alerts
* Required Fields